CD4 and tuberculosis: However, increased risk of developing further acquired immune deficiency syndrome-defining events or death in patients with a CD4 cell count of <100 cells/μl justify recommendations to start antiretroviral therapy as soon as possible in severely immunosuppressed HIV-infected patients coinfected with TB [5].